SCHEMBL4469502

SCHEMBL4469502

CCc1cc(CC2(N)N=C(N)C=CN2)on1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4467972 0.83 VHL (0.35)
SCHEMBL4461033 0.80 EPHX2 (0.34) EPHX2
SCHEMBL4460700 0.72 IGF1R (0.36)
SCHEMBL9285410 0.66
SCHEMBL443027 0.65
Hydrochloric Acid SCHEMBL4302835 0.64 NOTUM (0.43) EPHX2
SCHEMBL4466158 0.63 VHL (0.34)
SCHEMBL4456076 0.62 ALDH1A1 (0.38)
SCHEMBL9629469 0.62
SCHEMBL2038427 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed